PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PTC Therapeutics Inc
Other Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Other Operating Expenses
-$3.8m
CAGR 3-Years
37%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Operating Expenses
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Operating Expenses
$1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Operating Expenses
-$745m
CAGR 3-Years
-61%
CAGR 5-Years
-18%
CAGR 10-Years
-23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Operating Expenses
$48.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is PTC Therapeutics Inc's Other Operating Expenses?
Other Operating Expenses
-3.8m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Other Operating Expenses amounts to -3.8m USD.

What is PTC Therapeutics Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
39%

The average annual Other Operating Expenses growth rates for PTC Therapeutics Inc have been 37% over the past three years , 39% over the past five years .

Back to Top